HOME >> MEDICINE >> NEWS
Positive outcome of Medicare drug benefit

An editorial by Richard Platt, professor and chair of the Department of Ambulatory Care and Prevention (of Harvard Medical School and Harvard Pilgrim Health Care), says that an unintended effect of the Medicare Drug Benefit could be the creation of the world's most valuable resource for understanding how drugs are used, as well as their risks and benefits, especially among the elderly and chronically ill. This article appears in the Dec. 29 New England Journal of Medicine.

"This will be possible because drug dispensing can be linked to individuals' other health information," explains Platt. Covering more than 40 million people, Medicare data can transform our ability to assess drugs in real-life conditions, particularly in this vulnerable population of beneficiaries, which is often underrepresented in clinical trials.

The lack of systematic collection and analysis of post-marketing utilization and outcomes of medication has delayed discovery of some serious problems, which were only realized when millions of people were exposed. Therefore, it is important to review patients' full medical records in the small number of cases for which this information makes a critical difference. Two existing programs, one in the CDC and one in the FDA, share features that can be adopted for Medicare data.

Platt states that Medicare data will offer a great opportunity to improve the nation's ability to understand the balance of risks and benefits of drug treatment, and if taken advantage of, there will be increased data about whether drugs are used as intended, whether they have their intended effects, and how risky they are.


'"/>

Contact: John Lacey
public_affairs@hms.harvard.edu
Harvard Medical School
28-Dec-2005


Page: 1

Related medicine news :

1. Positive results more likely from industry-funded breast cancer trials
2. M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD
3. Positive parenting helps encourage healthy sun habits in children
4. Positive results for ACRUXs lead product in US Phase 3 trial
5. Positive study results for methylphenidate transdermal system
6. Positive study results for methylphenidate transdermal system
7. Comparison of obstetric outcomes between on-call and patients own obstetricians
8. LSUHSC awarded designation resulting in improved patient safety and outcomes
9. Treatment outcomes of patients with HIV and tuberculosis
10. Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
11. High pretreatment PSA velocity predicts worse outcome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology:
Cached News: